Gould and colleagues' state-of-the-art meta-analysis on the accuracy of positron emission tomography (PET) scanning for mediastinal staging in patients with non-small-cell lung cancer supports its use. However, the effect of PET scanning on patient outcomes is unknown, which is a major shortcoming of the evidence needed to support its wider use. Improved test sensitivity and specificity alone are not enough.
|Original language||English (US)|
|Number of pages||2|
|Journal||Annals of Internal Medicine|
|Publication status||Published - Dec 2 2003|
ASJC Scopus subject areas